BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 10623833)

  • 21. Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
    Jäger E; Salter R; Castelli C; Höhn H; Freitag K; Karbach J; Neukirch C; Necker A; Knuth A; Maeurer MJ
    J Immunol; 2002 Mar; 168(6):2766-72. PubMed ID: 11884444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential recognition of a retinal autoantigen peptide and its variants by rat T cells in vitro and in vivo.
    Wildner G; Diedrichs-Möhring M
    Int Immunol; 2003 Aug; 15(8):927-35. PubMed ID: 12882830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell selection and differential activation on structurally related HLA-DR4 ligands.
    Gebe JA; Novak EJ; Kwok WW; Farr AG; Nepom GT; Buckner JH
    J Immunol; 2001 Sep; 167(6):3250-6. PubMed ID: 11544312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response of a human T cell clone to a large panel of altered peptide ligands carrying single residue substitutions in an antigenic peptide: characterization and frequencies of TCR agonism and TCR antagonism with or without partial activation.
    Chen YZ; Matsushita S; Nishimura Y
    J Immunol; 1996 Nov; 157(9):3783-90. PubMed ID: 8892606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TCR reactivity in human nickel allergy indicates contacts with complementarity-determining region 3 but excludes superantigen-like recognition.
    Vollmer J; Weltzien HU; Moulon C
    J Immunol; 1999 Sep; 163(5):2723-31. PubMed ID: 10453014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations.
    Bhayani H; Paterson Y
    J Exp Med; 1989 Nov; 170(5):1609-25. PubMed ID: 2553848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell epitope prediction with combinatorial peptide libraries.
    Sung MH; Zhao Y; Martin R; Simon R
    J Comput Biol; 2002; 9(3):527-39. PubMed ID: 12162891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of peptide interaction with MHC creates TCR partial agonists.
    Ryan KR; McNeil LK; Dao C; Jensen PE; Evavold BD
    Cell Immunol; 2004 Jan; 227(1):70-8. PubMed ID: 15051516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex.
    Slansky JE; Rattis FM; Boyd LF; Fahmy T; Jaffee EM; Schneck JP; Margulies DH; Pardoll DM
    Immunity; 2000 Oct; 13(4):529-38. PubMed ID: 11070171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intercellular and intracellular events following the MHC-unrestricted TCR recognition of a tumor-specific peptide epitope on the epithelial antigen MUC1.
    Magarian-Blander J; Ciborowski P; Hsia S; Watkins SC; Finn OJ
    J Immunol; 1998 Apr; 160(7):3111-20. PubMed ID: 9531265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GPU-Accelerated Discovery of Pathogen-Derived Molecular Mimics of a T-Cell Insulin Epitope.
    Whalley T; Dolton G; Brown PE; Wall A; Wooldridge L; van den Berg H; Fuller A; Hopkins JR; Crowther MD; Attaf M; Knight RR; Cole DK; Peakman M; Sewell AK; Szomolay B
    Front Immunol; 2020; 11():296. PubMed ID: 32184781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies directed against the MHC-I molecule H-2Dd complexed with an antigenic peptide: similarities to a T cell receptor with the same specificity.
    Polakova K; Plaksin D; Chung DH; Belyakov IM; Berzofsky JA; Margulies DH
    J Immunol; 2000 Nov; 165(10):5703-12. PubMed ID: 11067928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes.
    Pinilla C; Rubio-Godoy V; Dutoit V; Guillaume P; Simon R; Zhao Y; Houghten RA; Cerottini JC; Romero P; Valmori D
    Cancer Res; 2001 Jul; 61(13):5153-60. PubMed ID: 11431354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TCR binding kinetics measured with MHC class I tetramers reveal a positive selecting peptide with relatively high affinity for TCR.
    Holmberg K; Mariathasan S; Ohteki T; Ohashi PS; Gascoigne NR
    J Immunol; 2003 Sep; 171(5):2427-34. PubMed ID: 12928390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptidic termini play a significant role in TCR recognition.
    Wang B; Sharma A; Maile R; Saad M; Collins EJ; Frelinger JA
    J Immunol; 2002 Sep; 169(6):3137-45. PubMed ID: 12218131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunobiological analysis of TCR single-chain transgenic mice reveals new possibilities for interaction between CDR3alpha and an antigenic peptide bound to MHC class I.
    Zhang W; Honda S; Wang F; DiLorenzo TP; Kalergis AM; Ostrov DA; Nathenson SG
    J Immunol; 2001 Oct; 167(8):4396-404. PubMed ID: 11591764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positional scanning-synthetic peptide library-based analysis of self- and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTL.
    Rubio-Godoy V; Dutoit V; Zhao Y; Simon R; Guillaume P; Houghten R; Romero P; Cerottini JC; Pinilla C; Valmori D
    J Immunol; 2002 Nov; 169(10):5696-707. PubMed ID: 12421949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of peptide residues interacting with MHC molecule or T cell receptor. Can a peptide bind in more than one way to the same MHC molecule?
    Kurata A; Berzofsky JA
    J Immunol; 1990 Jun; 144(12):4526-35. PubMed ID: 2141038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TCR ligand avidity determines the mode of B-Raf/Raf-1/ERK activation leading to the activation of human CD4+ T cell clone.
    Tsukamoto H; Irie A; Chen YZ; Takeshita K; Kim JR; Nishimura Y
    Eur J Immunol; 2006 Jul; 36(7):1926-37. PubMed ID: 16791876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.